ENTITY

Therapix Biosciences (TRPX US)

4
Analysis
Health CareUnited States
Therapix Biosciences Ltd provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. Therapix Biosciences serves customers worldwide.
more
17 Nov 2017 22:14Issuer-paid

Therapix Biosciences - Two new cannabinoid programs

Therapix is expanding its cannabinoid-based clinical pipeline beyond neurological disorders to potentially treat obstructive sleep apnea (OSA), a...

Share
18 Aug 2017 18:45Issuer-paid

THX-ULD01 to focus on TBI

Therapix reported H117 results and provided a company update in which it announced that the planned development program for sublingual ultra-low...

Share
29 Jun 2017 19:37Issuer-paid

Tackling neurology with cannabinoids

Therapix is investigating the potential of new formulations of cannabinoids to address underserved diseases of the brain. It recently listed on...

Share
07 Jun 2017 18:00Issuer-paid

Cannabinoids for underserved diseases

Therapix recently underwent an IPO on NASDAQ in the US of 2.3m ADS (worth $13.8m) to finance the clinical development of cannabinoid products. The...

Share
No more insights
x